Browsing by Subject "age 65"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Pneumococcal Vaccination Guidelines
    (2010-07-21) Noska, Amanda
    More research is needed to further evaluate cost-effectiveness and efficacy of PPV strategies (single vs. multiple doses). However, weak evidence suggests that for patients aged 65-80 who have not received the PPV previously, a single-dose PPV strategy is both clinically and economically indicated. For patients 65 and above who have already received one dose of the PPV vaccine, the decision whether to revaccinate depends of vaccine tolerance and the cost-effectiveness/willingness-to-pay threshold used.
  • Thumbnail Image
    Item
    Pneumococcal Vaccination Guidelines
    (2009-09-16) Noska, Amanda
    More research is needed to further evaluate cost-effectiveness and efficacy of PPV strategies (single vs. multiple doses). However, weak evidence suggests that for patients aged 65-80 who have not received the PPV previously, a single-dose PPV strategy is both clinically and economically indicated. For patients 65 and above who have already received one dose of the PPV vaccine, the decision whether to revaccinate depends of vaccine tolerance and the cost-effectiveness/willingness-to-pay threshold used.